Clinicopathologic characteristics and outcomes of Chinese patients with non‐small‐cell lung cancer and BRAF mutation

BRAF mutation is one of the important driver oncogene in non‐small‐cell lung cancer (NSCLC). Data on Chinese patients with BRAF‐mutant NSCLC are inadequate. Hence, we conducted this study to investigate the clinicopathologic features and outcomes of Chinese patients with NSCLC and BRAF mutations. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Xi, Zhang, Zengli, Jiang, Tao, Li, Xuefei, Zhao, Chao, Su, Bo, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345676/
https://www.ncbi.nlm.nih.gov/pubmed/28135039
http://dx.doi.org/10.1002/cam4.1014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345676/
https://www.ncbi.nlm.nih.gov/pubmed/28135039
http://dx.doi.org/10.1002/cam4.1014

Ejemplares similares